Table 3 Ocular findings regarding macular hole size and anatomical outcome
Characteristics | Group P conventional ILM peeling (n = 52) | Group F ILM flap technique (n = 65) | ||
|---|---|---|---|---|
MH-MLD (µm) | ≤ 400 n = 40 | > 400 n = 12 | ≤ 400 n = 39 | > 400 n = 26 |
Baseline BCVA, mean ± SD (logMAR), range | 0.72 ± 0.21 0.3–1.0 | 1.02 ± 0.23 0.52–1.3 | 0.8 ± 0.28 0.3–1.3 | 0.98 ± 0.32 0.4–1.6 |
Baseline MH-MLD, mean ± SD (µm), range *thereof, closed after first surgery | 289 ± 71 109–395 259 ± 63 109–365 | 598 ± 62 405–594 523 ± 100 452–594 | 288 ± 80 82–392 285 ± 80 82–392 | 500 ± 84.4 418–740 490 ± 82 418–740 |
Macular hole status closed/not closed, n (%) | 29/11 (72.5:27.5) | 2/12 (16.6:83.4) | 35/39 (89.7:10.3) | 23/26 (88.4:11.6) |
BCVA 1st follow-up, mean ± SD (logMAR), range * thereof, closed after first surgery | 0.53 ± 0.32 0–1.0 0.40 ± 0.25 0–1.0 | 0.96 ± 0.37 0.4–1.56 0.43 ± 0.04 0.4–0.46 | 0.46 ± 0.29 0.04–1.14 0.42 ± 0.27 0.04–1.14 | 0.57 ± 0.37 0.06–1.4 0.52 ± 0.35 0.06–1.3 |
BCVA 2nd follow-up, mean ± SD (logMAR), range * thereof, closed after first surgery | 0.52 ± 0.36 0–1.3 0.40 ± 0.27 0–1.0 | 0.89 ± 0.39 0.22–1.5 0.26 ± 0.05 0.22–0.3 | 0.40 ± 0.34 0.0–1.3 0.39 ± 0.34 0–1.3 | 0.53 ± 0.39 0–1.3 0.49 ± 0.36 0–1.3 |